An interesting possibility could be that the RBP4-STRA6 pathway is maintained at a resting state while bound to CaM resulting in a differentiated program, while its aberrant activation during colon cancer pathologies lead to increased stem cell properties and tumor progression. Here, RBP4 is linked to colonic neoplasm.